Open Accessibility Menu
Hide

Brijesh Bhambi, MD

About Brijesh

Dr. Brijesh Bhambi specializes in cardiac and vascular intervention, nuclear cardiology, consultative and general cardiology and holds board certification in Interventional Cardiology, Cardiovascular Disease, and Internal Medicine.  He completed his Internal Medicine Residency from New York Medical College and Cardiovascular Fellowship from Michael Reese Hospital in Chicago.  Additionally, while in Chicago he trained in molecular cardiology for one year.  Dr. Bhambi then continued on to Cedars-Sinai Medical Center in Los Angeles to finish his Fellowship training in Interventional Cardiology.  Dr. Bhambi chose Bakersfield as his home in 1992 and established private practice. 

Dr. Bhambi, as the Founding Member and Chairman of the Board of Bakersfield Heart Hospital (BHH) since 1998, constantly strives to better the lives of the Kern community by employing the latest interventional techniques and conducting leading-edge research in coronary and valvular heart disease.  Additionally, he is the Medical Director of Cardiac Cath Lab at BHH and serves as the Chairman of Centric Health, a clinically integrated multispecialty medical group based in Kern County.  He also serves as the Medical Director of QualCare IPA, a network of 300+ providers delivering quality healthcare to seniors throughout the Kern County.  As the organizational steward for Central Cardiology Medical Center, Dr. Bhambi collaborates with his colleagues to manage complex cardiac cases.  From his numerous clinical research trials and publications, Dr. Bhambi has gleaned advanced treatment options to offer to his patients.  Aside from research publications, Dr. Bhambi is a sought-after speaker in presenting clinical findings at major international Cardiovascular Conferences.

Dr. Bhambi brings a rigid discipline in not only his professional practice but also to his personal lifestyle where he keeps fit through daily weight training and long distance running. He regularly participates in marathons and has a passion for reading during his leisure.  Under the leadership and guidance of Dr. Bhambi, Central Cardiology Medical Center (CCMC) has become the largest premier Cardiology hub for cardiac patients to seek advanced treatment options.

Current Status:

  • Board Member - Kern County Medical Society, 2005
  • Board Member - Bakersfield Heart Hospital, 2003-present
  • Private Practice, 1992-present
    • Central Cardiology Medical Clinic
    • Cardiac and Vascular Interventionalist
    • Consultative and General Cardiology
    • Nuclear Cardiology
  • Lead interventionalist for a large cardiology group. Practice includes heavy emphasis on complex interventions including DCA, Excimer laser, Stent Angioplasty and Peripheral Interventions.
  • Director Nuclear Lab conducting over 1400 annual nuclear studies.
  • Director of Cardiac Cath Laboratory - Bakersfield Heart Hospital, 1999-present
  • Chief of Staff - Central Cardiology Medical Clinic, 1999-present
  • Staff Cardiologist
    • Bakersfield Memorial Hospital, Bakersfield
    • San Joaquin Community Hospital, Bakersfield
    • Kern Medical Center, Bakersfield
    • Bakersfield Heart Hospital
  • Proctor for J & J intracoronary stents.
  • Proctor for Boston Scientific Rotablader Atherectomy
Affiliations Kern County Medical Society, California Medical Association, American College of Angiology, American College of Cardiology, Society for Cardiac Angiography and Intervention
Awards
  • The Alfred Pick-Richard Langendorf Award, Michael Reese Hospital (Awarded to the most outstanding fellow)

    1990
Education
  • Board Certification
  • American Board of Internal Medicine, Interventional Cardiology 2002
  • American Board of Internal Medicine, Cardiovascular Diseases (Re-certification, 10TH Decile) 2001
  • American Board of Internal Medicine 1988
  • American Board of Internal Medicine (10TH Decile)
  • Cardiovascular Diseases (10TH Decile) 1991
  • Sri Guru Teg Bahadur Hospital, Internal Medicine Amritsar, Punjab, India
    1984
  • College
  • Pre-Medical, Guru Nanak Dev University Jalandhar, Punjab, India
    1976
  • Fellowship
  • Chief Cardiac Cath Lab Fellow and Interventional Cardiology Fellow Cedars-Sinai Medical Center
    Los Angeles, CA
    1992
  • Cardiology Michael Reese Hospital and Medical Center
    Chicago, IL
    1991
  • Molecular Cardiology University of Chicago
    Chicago, IL
    1990
  • Internship
  • Internal Medicine Lincoln Medical Center, New York Medical College
    New York, NY
    1987
  • Internal Medicine Amritsar, Punjab, India
    Sri Guru Teg Bahadur Hospital1981
  • Medical School
  • MBBS, Guru Nanak Dev University Jalandhar, Punjab, India
    1980
  • Residency
  • Internal Medicine Amritsar, Punjab, India
    Sri Guru Teg Bahadur Hospital1984
  • Internal Medicine Lincoln Medical Center, New York Medical College
    New York, NY
    1988
Medical Interests Publications
  • Sharma S, Bhambi B. Successful treatment of hypotension associated with stunned myocardium with oral midodrine therapy. J Cardiovasc Pharmacol Ther. 2005;10: 77-9.
  • Sharma S, Makkar RR, Bhambi B, Nyitray W, Desai K, Ishimori T. Intragraft administration of abciximab and verapamil combined with direct stenting prevents slow-flow and no-reflow phenomena in saphenous vein graft percutaneous coronary interventions. Catheter Cardiovasc Interv 2005; 65 B:119.B 43 (abstract).
  • Sharma S, Bhambi B. Vertebral artery stenting utilizing distal embolic protection withy Filter Wire and a drug eluting Taxus stent. (submitted)
  • Sharma S, Nyitray W, Bhambi B.Glycoprotein IIb/IIIa inhibition in percutaneous coronary interventions. JAMA. 2003; 290:1451.
  • Sharma S, Bhambi B, Nyitray W, Desai K, Davis D, Sharma G, Shukla P, File C, Ishimori T. Bivalirudin (Angiomax) use during intracoronary brachytherapy may predispose to acute closure. J Cardiovasc Pharmacol Ther 2003; 8:9-15.
  • Sharma S, Bhambi B, Nyitray W. Sirolimus-eluting coronary stents. N Engl J Med 2002; 347: 1285.
  • Sharma S, Nyitray W, Bhambi B. Brachytherapy and saphenous vein grafts. N Engl J Med 2002; 347: 692.
  • Sharma S, Bhambi B, Ishimori T. A better control for ICD patients? Eur Heart J 2002; 23:1972.
  • Sharma S, Bhambi B, Nyitray W, Desai K, Sharma G, Shukla P, Antonescu A, Denny E, Richardson K, Sadberry R, Ishimori T. Intragraft administration of abciximab and verapamil combined with direct stenting prevents slow-flow during saphenous vein graft percutaneous coronary interventions. Am J Cardiol 2002; 154 H.
  • Sharma S, Bhambi B, Nyitray W, Sharma G, Shambaugh S, Antonescu A, Shukla P, Denny E. Delayed profound thrombocytopenia presenting 7 days after use of abciximab (ReoPro). J Cardiovasc Pharmacol Ther 2002; 7(1):21-24.